DXR Daxor Corp. Net earnings per share growth this year

Official company branding of Daxor Corporation (DXR)

Daxor Corporation generates revenue through the sale of BVA-100 systems for blood volume monitoring. The annual relative change in EPS illustrates profit dynamics, where the -319.20 mark serves as the current indicator. The issuer collaborates with cardiology centers, implementing solutions for heart failure therapy. Patent protection and FDA certification create a significant barrier to entry for new players in this niche.

Earnings growth in current year: Daxor Corporation (DXR) for 07/04/2022 - 11/16/2026

Financial and market metric breakdowns for Daxor Corp. (DXR)

- stock price and consensus target price:
- market capitalization data:
Fundamental valuation:Daxor Corporation
Mass-produced product of Daxor Corp

This indicator measures the year-over-year dynamics of net earnings per share, determining the business scaling rate. By analyzing the annual EPS change, an investor can identify the acceleration or deceleration vector of profits. The metric is calculated as the percentage deviation of the current earnings value from the same period last year. For Daxor Corporation (DXR), such volatility is smoothed out by recurring payments for consumables. Stable demand for unique blood measurement systems ensures predictable growth of this fundamental parameter.

Main competitors

Abbott Corp. - Earnings per share increase in current year|Earnings per share growth in current year thermofisher.com|GEHC: Earnings per share increase in current year|Earnings growth in current year MTD|WAT - Earnings per share growth rate in current year|Earnings growth in current year TECH (bio-techne.com)|Bruker Corp. (BRKR) - Earnings per share growth rate in current year|Azenta - Earnings growth in current year|VREX (Varex Imaging) - Earnings per share growth this year|SMLR: Earnings growth in current year|BFLY - Expected net earnings per share growth this year|MLAB (Mesa Laboratories Corp.) - Earnings growth in current year|Earnings growth in current year Quantum-Si Corporation|Earnings growth in current year NNOX|Earnings growth in current year quanterix.com (QTRX)|Earnings per share growth in current year 908 Devices MASS|CapsoVision Inc (CV) - Earnings per share growth rate in current year|MXCT: Net earnings per share growth this year|Earnings per share increase in current year RPID (rapidmicrobio.com)|SEER: Earnings growth in current year|Earnings per share growth rate in current year hyperfine.io (HYPR)|Earnings per share growth in current year fonar.com|MDAI - Net earnings per share change in current year|Net earnings per share growth this year VIVS (Organovo)|Earnings growth in current year Aclarion Corp (ACON)|Earnings growth in current year AKYA (akoyabio.com)|Expected net earnings per share growth this year thermogenesis.com (THMO)|TLIS - Earnings per share growth in current year|Earnings per share trend in current year TTOO